Terazosin 68788-8171-03

Package NDC

68788-8171-03

Manufacturer: Preferred Pharmaceuticals Inc.
Dosage Form: Capsule
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: April 25, 2022
Listing Expires: December 31, 2026
Application: ANDA075614

Need to source Terazosin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Terazosin Hydrochloride	2 mg/1

Drug Class

Adrenergic alpha-Antagonists [MoA]alpha-Adrenergic Blocker [EPC]

Selected Package

68788-8171-03Selected

30 CAPSULE in 1 BOTTLE (68788-8171-3)